Tuesday, February 28, 2012

New data show that FIRMAGON® (degarelix) is non-inferior to the combination of goserelin plus bicalutamide at reducing prostate volume in patients with advanced hormone-dependent prostate cancer while offering better relief from lower urinary tract symptoms

|More|
Wednesday, February 08, 2012

Ferring announces new million euro educational initiative with International Federation of Fertility Societies (IFFS) and Elsevier

|More|
 

By using the service, you agree to the following:

Your email address and the recipient's email address will be used for transmission purposes only - to inform the addressee about the sender, or for sending a message in the event of a transmission error. Both email addresses will be deleted from our system after a short period.